Ignite Creation Date:
2024-05-06 @ 3:52 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04781855
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-03
First Post:
2021-02-24
Brief Title:
Ipilimumab Ibrutinib and Nivolumab for the Treatment of Chronic Lymphocytic Leukemia and Richter Transformation
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Richter Syndrome |
| Hematopoietic and Lymphoid Cell Neoplasm |
| Recurrent Chronic Lymphocytic Leukemia |
| Recurrent Small Lymphocytic Lymphoma |
| Refractory Chronic Lymphocytic Leukemia |
| Refractory Small Lymphocytic Lymphoma |
Keywords: